Plain-English translation of NCT06611579 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new device called the inQB8 MonarQ Transcatheter Tricuspid Valve Replacement System, which is designed to fix a leaky tricuspid valve in your heart. Instead of traditional open-heart surgery, this treatment uses a catheter — a thin tube — to place the new valve through your blood vessels. The study will track how safe and effective this new approach is for people with severe tricuspid valve leakage.
Many people with a severely leaky tricuspid valve have symptoms like shortness of breath and swelling, but surgery is risky or not an option for them. This study exists to see if this new minimally invasive device can help these patients without the risks of traditional surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive the new tricuspid valve replacement procedure through a catheter inserted into your blood vessels — avoiding open-heart surgery. After the procedure, you would attend follow-up visits so the research team can monitor how well the device is working and check for any side effects. The study involves about 50 participants and requires you to complete all follow-up appointments over the study period.
AI-generated summary from trial data · Aug 9, 2026 · Not medical advice
United States